Updated Story HHS announced plans Wednesday (Oct. 28) to pay Eli Lilly up to $1.187 billion for 950,000 vials of a coronavirus antibody drug, on the condition that FDA authorizes it for emergency use, which would come out to $1,250 per treatment, similar to the $1,500 price per treatment of Regeneron’s experimental antibody drug. The purchase agreement with Lilly is part of the government’s plan to buy enough antibody drugs to last until a coronavirus vaccine is...